We are live on
!
Find out more
HCMT
Highland Capital Management (Tennessee) Portfolio holdings
AUM
$2.17B
1-Year Est. Return
54.74%
This Fund
S&P 500
This Quarter
Est. Return
-2.88%
1 Year Est. Return
+54.74%
3 Year Est. Return
+141.9%
5 Year Est. Return
+171.7%
10 Year Est. Return
+576.48%
AUM
$1.67B
AUM Growth
-$96.4M
(-5.5%)
Cap. Flow
-$16M
Cap. Flow
% of AUM
-0.96%
Top 10 Holdings %
Top 10 Hldgs %
26.15%
Holding
355
New
17
Increased
148
Reduced
103
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$5.3M |
| 2 |
Welltower
WELL
|
+$5.04M |
| 3 |
Realty Income
O
|
+$4.96M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$4.85M |
| 5 |
MetLife
MET
|
+$4.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$10.9M |
| 2 |
Costco
COST
|
+$7.1M |
| 3 |
Walt Disney
DIS
|
+$6.72M |
| 4 |
Jones Lang LaSalle
JLL
|
+$5.34M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$4.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.23% |
| 2 | Financials | 12.8% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 9.3% |
| 5 | Communication Services | 7.38% |
Similar funds
ET
SIG
MIAS
ICM
TAL
CAG
IIP
ORCP
Highland Capital Management (Tennessee)'s Q1 2022 Portfolio in Review
As of Q1 2022, Highland Capital Management (Tennessee) held 355 positions worth $1.67B, down 5.5% from $1.77B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Highland Capital Management (Tennessee)'s Q1 2022 filing shows 17 new, 148 increased, 103 reduced and 26 closed positions. Its largest new stake was Jazz Pharmaceuticals: 36,550 shares worth $5.69M. The largest sale was Freeport-McMoran, an estimated $10.9M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Highland Capital Management (Tennessee)'s largest Q1 2022 buy was Jazz Pharmaceuticals: 36,550 shares worth $5.69M.
- Highland Capital Management (Tennessee) added most to Thermo Fisher Scientific in Q1 2022, an estimated $4.85M increase.
- Highland Capital Management (Tennessee)'s biggest Q1 2022 reduction was Freeport-McMoran, cutting an estimated $10.9M.
- Highland Capital Management (Tennessee) fully exited Jones Lang LaSalle in Q1 2022, selling an estimated $5.34M.
- Highland Capital Management (Tennessee)'s ten largest holdings make up 26% of its $1.67B portfolio in Q1 2022.
- Highland Capital Management (Tennessee) opened 17 new positions and closed 26 in Q1 2022.
- Highland Capital Management (Tennessee)'s portfolio value fell 5.5% quarter-over-quarter to $1.67B.
Based on Highland Capital Management (Tennessee)'s 13F filing for Q1 2022, filed 19 Apr 2022.